The Lift Line
“Before the camera enters the chemist, the government needs to answer a more fundamental question: Who will be watching the watcher?”
Why This Editorial Matters for Your Exam
Ameer Shahul, author of Vaccine Nation (2025) and The Silent Syndicate, takes a health-regulation proposal and tests it against the right to privacy. It is a model for applying the proportionality test, useful in GS2 and GS4, and pairs with The Hindu’s op-ed today on surveillance as a chain.
GS Paper 2: Health; government policies and interventions; fundamental rights. GS Paper 4: Ethics of surveillance; privacy and dignity.
Background and Context
The proposal. According to the column, the Union Ministry of Health and Family Welfare has begun a process to allow the sale of prescription drugs only under CCTV surveillance across the country by early 2027.
How prescription drugs are regulated.
| Category | Meaning |
|---|---|
| Schedule H | Prescription-only drugs; sold only on a registered medical practitioner’s prescription |
| Schedule H1 | Introduced in 2013: certain antibiotics, anti-TB drugs and habit-forming drugs; pharmacist must keep a separate register (prescriber, patient, drug, quantity) for three years |
| Schedule X | Narcotic and psychotropic substances; stricter records and prescription retention |
The law is the Drugs and Cosmetics Act, 1940 and the Drugs Rules, 1945, enforced by State drug controllers; the Central Drugs Standard Control Organisation (CDSCO) under the Drugs Controller General of India (DCGI) approves drugs and coordinates.
The privacy yardstick. K.S. Puttaswamy v. Union of India (2017): any intrusion must satisfy legality, a legitimate aim, proportionality (suitability, necessity, balancing) and procedural safeguards. The column invokes exactly these: legality, necessity and proportionality.
The Analysis
1. The benefits are real but narrow. An audit trail helps inspectors act on complaints and track diversion of Schedule H1 and X drugs.
2. A pharmacy is not a shop like any other. A camera records who buys antidepressants, anti-epileptics, HIV medicines, fertility drugs, abortion pills, sexual health medicines, cancer drugs or psychiatric drugs. Face plus time plus medicine is a health profile.
3. Over-inclusive by design. Most prescription sales (antibiotics, antihypertensives, anti-diabetics) are not high-risk transactions. Why film them all?
4. The camera cannot see the fraud. It shows a paper crossing the counter, not whether the prescription is genuine.
5. The footage problem. Who can access it: the drug inspector, the police, other departments? For what purposes? Can it be copied, linked to other databases or run through facial recognition? Will citizens know? Three months of footage could map a person’s health behaviour.
6. Enforce what exists first. Prescription rules, registers, licensing and inspections already exist; the first question is whether they are enforced.
Data and Institutions Vault
Prelims-grade facts:
Drug regulation:
- Drugs and Cosmetics Act, 1940; Drugs Rules, 1945; CDSCO under the Ministry of Health; head: DCGI.
- Schedule H1 (2013): separate sale register kept for 3 years; red-label warning on the pack.
- Schedule X: narcotic and psychotropic drugs; stricter controls.
- Kerala runs Operation AMRITH (2024) against over-the-counter antibiotic sales.
Privacy:
- Puttaswamy (2017): privacy under Article 21; proportionality test.
- DPDP Act, 2023: applies to digital personal data, including health data; no separate “sensitive data” class.
⚠️ Watch the trap: Drug quality and licensing of retail pharmacies are enforced by State drug control departments; the CDSCO approves new drugs and regulates imports and clinical trials. Drug prices are set by the NPPA.
The Debate
For the author’s view. Surveillance of every patient to catch a few rogue pharmacies fails the necessity test; less intrusive tools exist.
The complications. Over-the-counter antibiotic sales drive antimicrobial resistance (AMR), one of India’s gravest health threats, and inspection capacity is thin. A camera is a cheap deterrent, and footage could be protected by design.
The balanced verdict. Use targeted tools first: e-prescriptions verified at the counter, electronic registers for H1 and X drugs, more inspectors and real penalties. If cameras are used, limit them to high-risk sales, with tight access, short retention and no facial recognition.
How to Think About This
Run the four-step test aloud. For any surveillance proposal, ask: Is there a law? Is the aim legitimate? Is it the least intrusive effective means? Do the benefits outweigh the harm to rights? Answers that walk through these steps score well in both GS2 and GS4.
Diagram-in-Words
Over-the-counter sale of prescription medicines is a public health risk, but surveillance-based solutions raise privacy concerns. Evaluate the proposal to mandate CCTV monitoring of prescription drug sales in the light of the proportionality test. (250 words)
India regulates prescription medicines under the Drugs and Cosmetics Act, 1940 and the Drugs Rules, 1945, which require a prescription for Schedule H, H1 and X drugs and records for the more sensitive categories. Enforcement is weak, and non-prescription sales of antibiotics and habit-forming drugs are common, contributing to antimicrobial resistance and misuse.
A proposal to allow prescription sales only under CCTV surveillance promises an audit trail and deterrence. But under the proportionality test of K.S. Puttaswamy (2017), a restriction on privacy must have a legal basis, pursue a legitimate aim, be suitable and necessary, with no less intrusive alternative, and be balanced.
Blanket filming fails several of these tests. It is over-inclusive, capturing every patient’s purchase of sensitive medicines such as antidepressants, HIV drugs, fertility drugs or abortion pills; health data is among the most sensitive personal data.
It may not be suitable, since a camera cannot verify whether a prescription is genuine. Less intrusive alternatives exist: stronger inspection and licensing, digital e-prescriptions verified at the counter, mandatory electronic sale registers for Schedule H1 and X drugs, and penalties for violators.
If cameras are used at all, they should be limited to high-risk drugs, with strict access controls, short retention, audit logs, a bar on linkage with facial recognition, and obligations under the Digital Personal Data Protection Act, 2023.
More data is not the same as better regulation. Targeted digital records and effective enforcement would curb misuse of medicines while respecting the privacy that patients are entitled to.
Interview Angle
"Antibiotics and habit-forming drugs are sold without prescriptions across India. Would you support CCTV in pharmacies as a Drugs Controller? What safeguards would you insist on?"
Takeaway Box
- Proposal: CCTV for prescription drug sales nationwide by early 2027 (as the column reports).
- Author’s objection: records sensitive health data; cannot verify prescriptions.
- Law: Drugs and Cosmetics Act 1940; Schedules H, H1 (2013), X.
- Test: Puttaswamy proportionality; least intrusive means.
- Fix: enforce existing rules; e-prescriptions; narrow, safeguarded use if any.
Sources: The Indian Express, CDSCO, Ministry of Health and Family Welfare
Ameer Shahul argues that the Health Ministry’s move to allow prescription drug sales only under CCTV surveillance by early 2027 would record intimate health information about every patient while doing little to fix the real problem, which is weak enforcement of existing drug rules.
- Cameras can create an audit trail and help inspectors act against pharmacies that sell without prescriptions, especially for Schedule H1 and X drugs.
- But a camera at a chemist records who buys antidepressants, HIV medicines, fertility drugs, abortion pills or cancer treatment; face, time and medicine together reveal a person’s health.
- Blanket filming treats every prescription sale, including antibiotics or antihypertensives, as high-risk.
- A camera cannot tell whether a prescription is genuine; it documents a transaction without solving the regulatory problem.
- Key questions are unanswered: who can access the footage, for what purposes, whether it can be linked to other databases or facial recognition, and whether citizens will know it was accessed.
Over-the-counter sales of antibiotics and habit-forming drugs fuel antimicrobial resistance and addiction, and inspection capacity is thin; CCTV is a cheap deterrent and audit tool that could be designed with privacy safeguards.
Strengthen inspection and licensing first; if cameras are used, confine them to high-risk Schedule H1 and X transactions, restrict access and retention, bar linkage with facial recognition, and move to digital, verifiable e-prescriptions.
Cite this page: CCTV Is No Cure for Weak Drug Regulation: Cameras at Chemists and the Privacy of Patients — Ujiyari.com | Free UPSC & State PCS Editorial Analysis